Boris Bleijlevens

2.7k citations

40 papers · 2.0k indexed · 1 hit paper · h-index 21

Molecular Biology top 10%
Renewable Energy, Sustainability and the Environment top 5%
Endocrinology, Diabetes and Metabolism top 5%
Physiology top 5%
Surgery

Co-authors: Simon P. J. Albracht Sílvia D. Olabarriaga Mohammad Mahdi Jaghoori Bärbel Friedrich Markus W. Hollmann Johannes M. F. G. Aerts Ruben Coronel Anneke Koeman
Topics: Metalloenzymes and iron-sulfur proteins (11 papers)Lysosomal Storage Disorders Research (6 papers)Electrocatalysts for Energy Conversion (5 papers)
Cited by: Renewable Energy, Sustainability and the Environment Endocrinology, Diabetes and Metabolism Physiology
Journals: Journal of Biological Chemistry Blood The Journal of Immunology
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

Boris Bleijlevens

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation

2017 466 citations Laween Uthman, Antonius Baartscheer et al. Diabetologia profile →

Peers

Countries citing papers authored by Boris Bleijlevens

Since Specialization

Citations

This map shows the geographic impact of Boris Bleijlevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Bleijlevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Bleijlevens more than expected).

Fields of papers citing papers by Boris Bleijlevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Bleijlevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Bleijlevens. The network helps show where Boris Bleijlevens may publish in the future.

Co-authorship network of co-authors of Boris Bleijlevens

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Bleijlevens. A scholar is included among the top collaborators of Boris Bleijlevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Bleijlevens. Boris Bleijlevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increasing the odds: antibody-mediated delivery of two distinct immunogenic T-cell epitopes with one antibody 2025 ·OncoImmunology ·(unknown),Dennis F.G. Remst,(unknown),Anne K. Wouters,Maaike E. Ressing,Janine Schuurman,Sander I. van Kasteren,Boris Bleijlevens,Rob C. Hoeben,Lars Guelen,Mirjam H.M. Heemskerk	0
2	Characterization of antibody Fc:Fc interactions by a VHH blocking technology 2025 ·Immunobiology ·Els van der Meijden,(unknown),Alexandra M. Terry,(unknown),(unknown),(unknown),(unknown),(unknown),Dennis Verzijl,Boris Bleijlevens,Adam W. Barb,Rob N. de Jong,Frank J. Beurskens	0
3	Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells 2023 ·Cancer Gene Therapy ·(unknown),Dennis F.G. Remst,Michel G.D. Kester,Renate S. Hagedoorn,Paul W.H.I. Parren,Sander I. van Kasteren,Janine Schuurman,Rob C. Hoeben,Maaike E. Ressing,Boris Bleijlevens,Mirjam H.M. Heemskerk	4
4	Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilationbreakdown → 2017 ·Diabetologia ·Laween Uthman,Antonius Baartscheer,Boris Bleijlevens,Cees A. Schumacher,Jan W.T. Fiolet,Anneke Koeman,(unknown),Markus W. Hollmann,Nina C. Weber,Ruben Coronel,Coert J. Zuurbier	466
5	LRSAM1-mediated ubiquitylation is disrupted in axonal Charcot–Marie–Tooth disease 2P 2017 ·Human Molecular Genetics ·(unknown),Vincenzo Sorrentino,(unknown),Marit B. de Wissel,Marlene van den Berg,Boris Bleijlevens,Fred van Ruissen,Ben Distel,Frank Baas,Noam Zelcer,Marian A. J. Weterman	11
6	1001 Ways to run AutoDock Vina for virtual screening 2016 ·Journal of Computer-Aided Molecular Design ·Mohammad Mahdi Jaghoori,Boris Bleijlevens,Sílvia D. Olabarriaga	141
7	Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL) 2011 ·Journal of Biological Chemistry ·Vincenzo Sorrentino,(unknown),Ana Santos,Eric A. Reits,Boris Bleijlevens,Noam Zelcer	43
8	Ultrasensitive in situ visualization of active glucocerebrosidase molecules 2010 ·Nature Chemical Biology ·Martin D. Witte,Wouter W. Kallemeijn,Jan Aten,Kah‐Yee Li,Anneke Strijland,Wilma E. Donker‐Koopman,Adrianus M. C. H. van den Nieuwendijk,Boris Bleijlevens,Gertjan Kramer,Bogdan I. Florea,Berend Hooibrink,Carla E. M. Hollak,Roelof Ottenhoff,Rolf G. Boot,Gijsbert A. van der Marel,Herman S. Overkleeft,Johannes M. F. G. Aerts	194
9	Classification-based comparison of pre-processing methods for interpretation of mass spectrometry generated clinical datasets 2009 ·Proteome Science ·(unknown),Perry D. Moerland,Marrije R. Buist,(unknown),Boris Bleijlevens,Huub C. J. Hoefsloot,Chris G. de Koster,Johannes M. F. G. Aerts	9
10	Dynamic states of the DNA repair enzyme AlkB regulate product release 2008 ·EMBO Reports ·Boris Bleijlevens,(unknown),Emily Flashman,Yi Yang,P. J. Simpson,Pertti Koivisto,Barbara Sedgwick,Christopher J. Schofield,Stephen Matthews	52
11	Structural insights into microneme protein assembly reveal a new mode of EGF domain recognition 2008 ·EMBO Reports ·Kovilen Sawmynaden,Savvas Saouros,Nikolas Friedrich,Jan Marchant,P. J. Simpson,Boris Bleijlevens,Michael J. Blackman,Dominique Soldati‐Favre,Stephen Matthews	25
12	Replacement of non-heme Fe(II) with Cu(II) in the α-ketoglutarate dependent DNA repair enzyme AlkB: Spectroscopic characterization of the active site 2007 ·Journal of Inorganic Biochemistry ·Boris Bleijlevens,(unknown),Barbara Sedgwick,Stephen E. J. Rigby,Stephen Matthews	15
13	Detection of mutant protein in complex biological samples: Glucocerebrosidase mutations in Gaucher’s disease 2007 ·Analytical Biochemistry ·Boris Bleijlevens,Mariëlle J. van Breemen,Wilma E. Donker‐Koopman,Chris G. de Koster,Johannes M. F. G. Aerts	4
14	Characterization of a HoxEFUYH type of [NiFe] hydrogenase from Allochromatium vinosum and some EPR and IR properties of the hydrogenase module 2006 ·JBIC Journal of Biological Inorganic Chemistry ·Minnan Long,Jingjing Liu,Zhifeng Chen,Boris Bleijlevens,Winfried Roseboom,Simon P. J. Albracht	34
15	Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry 2006 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Mariëlle J. van Breemen,Boris Bleijlevens,Chris G. de Koster,Johannes M. F. G. Aerts	12
16	Characterization of a cyanobacterial-like uptake [NiFe] hydrogenase: EPR and FTIR spectroscopic studies of the enzyme from Acidithiobacillus ferrooxidans 2006 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown),Boris Bleijlevens,(unknown),Zhujun Chen,Tianshu Li,Jörg Fischer,Jochen Förster,Cornelius G. Friedrich,Kimberly A. Bagley,Simon P. J. Albracht,Wolfgang Lubitz	27
17	The Auxiliary Protein HypX Provides Oxygen Tolerance to the Soluble [NiFe]-Hydrogenase of Ralstonia eutropha H16 by Way of a Cyanide Ligand to Nickel 2004 ·Journal of Biological Chemistry ·Boris Bleijlevens,Thorsten Buhrke,Eddy van der Linden,Bärbel Friedrich,Simon P. J. Albracht	59
18	The soluble [NiFe]-hydrogenase from Ralstonia eutropha contains four cyanides in its active site, one of which is responsible for the insensitivity towards oxygen 2004 ·JBIC Journal of Biological Inorganic Chemistry ·Eddy van der Linden,Tanja Burgdorf,Michael Bernhard,Boris Bleijlevens,Bärbel Friedrich,Simon P. J. Albracht	54
19	Involvement of hyp gene products in maturation of the H2-sensing [NiFe] hydrogenase of Ralstonia eutropha. 2001 ·Journal of Biological Chemistry ·Thorsten Buhrke,Boris Bleijlevens,Simon P. J. Albracht,(unknown)	3
20	The [NiFe] hydrogenase from Allochromatium vinosum studied in EPR-detectable states: H/D exchange experiments that yield new information about the structure of the active site 2001 ·JBIC Journal of Biological Inorganic Chemistry ·Boris Bleijlevens,Bart W. Faber,Simon P. J. Albracht	48

About Boris Bleijlevens

Boris Bleijlevens is a scholar working on Renewable Energy, Sustainability and the Environment, Parasitology and Information Systems and Management, having authored 40 papers that have together received 2.0k indexed citations. Recurring topics across this work include Metalloenzymes and iron-sulfur proteins (11 papers), Lysosomal Storage Disorders Research (6 papers) and Electrocatalysts for Energy Conversion (5 papers). The work is most often cited by research in Renewable Energy, Sustainability and the Environment (467 citations), Endocrinology, Diabetes and Metabolism (415 citations) and Physiology (368 citations). Boris Bleijlevens has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Simon P. J. Albracht, Sílvia D. Olabarriaga, Mohammad Mahdi Jaghoori, Bärbel Friedrich, Markus W. Hollmann, Johannes M. F. G. Aerts, Ruben Coronel, Anneke Koeman, Cees A. Schumacher and Jan W.T. Fiolet. Their work appears in journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact